Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
April 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 |
May 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
Press releases published on May 21, 2025
Back By Popular Demand: Valerie Van Booven & Dawn Fiala to Present Two Powerhouse Sessions at HomeCareCon 2025
EIN Presswire
·
May 21, 2025
Nationally recognized home care marketing experts Valerie Van Booven, RN BSN and Dawn Fiala are set to return to HomeCareCon 2025 by popular demand. ORLANDO, FL, UNITED STATES, May 21, 2025 /EINPresswire.com/ -- Nationally recognized home care marketing …
Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline
GlobeNewswire
·
May 21, 2025
Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline Paris, May 22, 2025. Sanofi announced today that it has entered into an agreement to acquire Vigil Neuroscience, Inc. …
Communiqué de presse : Sanofi va acquérir Vigil Neuroscience, Inc. et ajouter un nouveau médicament expérimental pour le traitement de la maladie d’Alzheimer à son portefeuille en neurologie
GlobeNewswire
·
May 21, 2025
Sanofi va acquérir Vigil Neuroscience, Inc. et ajouter un nouveau médicament expérimental pour le traitement de la maladie d’Alzheimer à son portefeuille en neurologie Paris, le 22 mai 2025. Sanofi annonce aujourd’hui avoir conclu un accord en vue de l’ …
Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters’ Option to Purchase Additional Shares, and Closing of Private Placement
GlobeNewswire
·
May 21, 2025
Public offering results in gross proceeds of $57.5 million Private placement results in gross proceeds of approximately $20.3 million GERMANTOWN, Md., May 21, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology …
Premier Health Reports 2025 Second Quarter Results
GlobeNewswire
·
May 21, 2025
MONTRÉAL, May 21, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Company”), a leading Canadian Healthtech company, announces it has filed its unaudited Quarterly Consolidated Financial Statements and MD…
'Forever Chemicals, Lasting Harm': Legal Claim Assistant Warns of Long-Term Health Risks from PFAS Exposure
EIN Presswire
·
May 21, 2025
PFAS exposure linked to cancer, infertility, and immune disorders—Legal Claim Assistant offers free legal help to affected victims. MIAM, FL, UNITED STATES, May 21, 2025 /EINPresswire.com/ -- Legal Claim Assistant is urging Americans to come forward as …
Vaxart Announces Adjournment of Annual Meeting of Stockholders
GlobeNewswire
·
May 21, 2025
Meeting adjourned to June 2, 2025 at 8:30 a.m. Pacific Time Vaxart encourages all stockholders of record on March 26, 2025 who have not yet voted to do so by 11:59 p.m. Eastern Time on June 1, 2025 SOUTH SAN FRANCISCO, Calif., May 21, 2025 (GLOBE NEWSWIRE) …
Cellectis’ Annual Shareholders General Meeting to be Held on June 26, 2025
GlobeNewswire
·
May 21, 2025
NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today …
Olema Oncology to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 21, 2025
SAN FRANCISCO, May 21, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …
Longevity Health Holdings Announces Continued Nasdaq Listing to Complete Merger With 20/20 Biolabs
GlobeNewswire
·
May 21, 2025
PITTSBURGH, May 21, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE) (“XAGE,” the “Company,” “we,” “us,” or “our”), a company focused on extending human longevity and healthy aging through innovative products in regenerative bio- …
CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report
GlobeNewswire
·
May 21, 2025
Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth Debuts enhanced greenhouse gas accounting across Scopes 1-3 and advances renewable energy initiatives Strengthens governance …
Nanobiotix Provides First Quarter 2025 Operational and Financial Update
GlobeNewswire
·
May 21, 2025
Dosing of a first patient in the CONVERGE study, a Phase 2 randomized controlled clinical trial for patients with stage 3 unresectable non-small cell lung cancer Presentation of data at the European Lung Cancer Conference in a Phase 1 study of re- …
Nanobiotix fait le point sur sa trésorerie et son activité opérationnelle du premier trimestre 2025
GlobeNewswire
·
May 21, 2025
Traitement du premier patient dans l’étude CONVERGE, un essai clinique contrôlé randomisé de Phase 2 chez des patients atteints d’un cancer du poumon non à petites cellules (CPNPC) non résécable de stade 3. Présentation de données à l’ELCC (European Lung …
Codexis to Participate in Jefferies Global Healthcare Conference
GlobeNewswire
·
May 21, 2025
REDWOOD CITY, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will attend the Jefferies Global Healthcare …
Maravai LifeSciencesReleases 2024 Sustainability Report
GlobeNewswire
·
May 21, 2025
Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth Debuts enhanced greenhouse gas accounting across Scopes 1-3 and advances renewable energy initiatives Strengthens governance …
Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference
GlobeNewswire
·
May 21, 2025
SOUTH SAN FRANCISCO, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company led oral and poster presentations of clinical and preclinical data this week as part of the American Thoracic Society ( …
Immix Biopharma to Host KOL Event to Discuss NXC-201 Clinical Data Presented at ASCO 2025 in relapsed/refractory AL Amyloidosis
GlobeNewswire
·
May 21, 2025
– Virtual KOL Event Tuesday, June 3, 2025 3:00pm ET – – Attend the event here: https://lifescievents.com/event/immix-asco – LOS ANGELES, CA, May 21, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), clinical- …
AI와 알고리즘 구동 플랫폼 TrialWire, Fierce CRO Award “우수 환자 모집 및 유지” 부문 최종 후보로 선정
GlobeNewswire
·
May 21, 2025
샌프란시스코, May 22, 2025 (GLOBE NEWSWIRE) -- TrialWire가 Fierce Biotech의 Fierce CRO Award 우수 환자 모집 및 유지 부문에서 최종 후보로 선정되었다. TrialWire는 AI와 알고리즘으로 구동되는 환자 모집 및 등록 플랫폼으로, Salesforce Health Cloud를 기반으로 설계되어 최상급의 데이터 및 IP 보안을 보장한다. 이 플랫폼은 등록 환자당 요금을 지불하는 위험 분담형 …
人工智能和算法驱动的平台 TrialWire 荣获 Fierce CRO 奖项“杰出患者招募与留存”类目提名，进入决赛阶段
GlobeNewswire
·
May 21, 2025
旧金山, May 22, 2025 (GLOBE NEWSWIRE) -- TrialWire 今日宣布荣获 Fierce Biotech 主办的 Fierce CRO 奖项杰出患者招募与留存类目提名，闯入决赛。 TrialWire 是基于 Salesforce Health Cloud 构建的人工智能和算法驱动的患者招募和入组特色平台，具备一流的数据和知识产权安全保障。 …
TrialWire 以人工智能及演算法驅動的平台，在 Fierce CRO Award 的「傑出患者招募及保留」類別中，獲得決賽席位
GlobeNewswire
·
May 21, 2025
三藩市, May 22, 2025 (GLOBE NEWSWIRE) -- TrialWire 今天宣佈於 Fierce CRO Award 的 「傑出患者招募及保留」類別中，獲 Fierce Biotech 挑選成為參加決賽的一分子。 TrialWire 是一個建構於 Salesforce Health Cloud 之上，採用人工智能及演算法驅動的患者招募和註冊平台，以確保一流的數據和 IP 安全性。 …